News
23h
Barchart on MSNDo Wall Street Analysts Like Insulet Stock?Acton, Massachusetts-based Insulet Corporation (PODD) is a medical device company that develops, manufactures, and sells ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $332.0, a high estimate of $380.00 ...
Insulet stock has soared 81% over the last 12 months, buoyed by the Food and Drug Administration’s approval of the company’s ...
(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, is proud to announce the publication of its 2024 Sustainability Report.
Insulet develops, manufactures, and markets the Omnipod Insulin Management System for people with diabetes. This system is worn on the body for approximately three days at a time and allows ...
The firm has carved a path to meaningful profitability gains. Until Insulet's Omnipod came on the market at the end of 2005, all insulin pumps consisted of a controller and insulin reservoir ...
Insulet Corporation demonstrated strong financial and operational performance in Q1 2025, with significant revenue and margin growth driven by the Omnipod 5 platform. Under new CEO Ashley McEvoy's ...
Pavlo Gonchar / SOPA Images / LightRocket via Getty Images Insulet announced announced Ashley McEvoy would replace Jim Hollingshead as CEO. The maker of the Omnipod insulin pump for diabetics also ...
Insulet produces and sells Omnipod, an automated insulin delivery device that operates without external tubing, unlike conventional pumps, and eliminates the need for multiple daily injections for ...
FDA clears its first automated insulin pump for Type 2 diabetes with Insulet's Omnipod 5 In its announcement of the leadership change, Insulet said that Hollingshead and the company mutually ...
Big Money buying shares of Insulet Corporation (PODD). Insulet develops, manufactures, and markets the Omnipod Insulin Management System for people with diabetes. This system is worn on the body ...
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, is proud to announce the publication of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results